MID-ATLANTIC NODE

MID-ATLANTIC NODE

Lead Investigators:
Maxine Stitzer, PhD
[email]
Johns Hopkins University
School of Medicine
5510 Nathan Shock Dr.
Suite 1500
Baltimore, MD 21224-6823

Robert P. Schwartz, MD [email]
Friends Research Institute, Inc.
1040 Park Ave., Suite 103
Baltimore, MD 21201

Find Node Publications
Node Facebook page
Node's Motivational Incentives web site
NIDA web site

The Mid-Atlantic Node joined the Clinical Trials Network in September 1999 and includes Maryland, Virginia, and Washington DC.

The CTP network provides about 5,000 treatment slots serving a diverse group of people suffering from substance use disorder, which is often complicated by other psychiatric and medical illnesses.


MID-ATLANTIC NODE PROTOCOL INVOLVEMENT

CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults
CTN-0010-A-2 Comorbid Conditions in Adolescents with Opioid Versus Alcohol/Marijuana Use Disorders
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0020 Job Seekers Training for Patients with Drug Dependence
CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0032 HIV Rapid Testing and Counseling
CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
CTN-0051-A-1 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study
CTN-0059 Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief Screen/Assessment Tool
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users
Johns Hopkins Friends Research Institute
RRTC Site | www
RRTC Site
www
| search
VCU Institute for Drug & Alcohol Studies
RRTC Site | www www | search
Chase Brexton
www | search www | search
Chesterfield CSB Richmond Behavioral Health Authority
www | search
www | search
No web site available Total Health Care, Inc.
www | search
www | search
Harbel Universal Counseling Services, Inc.
www | search
www | search
Harbel Whitman-Walker Clinic
www | search
www | search
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2016 -- http://ctndisseminationlibrary.org/nodes/manode.htm
info@ctndisseminationlibrary.org